000 | 01971 a2200589 4500 | ||
---|---|---|---|
005 | 20250516223604.0 | ||
264 | 0 | _c20150226 | |
008 | 201502s 0 0 eng d | ||
022 | _a1097-6809 | ||
024 | 7 |
_a10.1016/j.jvs.2014.05.047 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aConrad, Mark F | |
245 | 0 | 0 |
_aThe natural history of asymptomatic severe carotid artery stenosis. _h[electronic resource] |
260 |
_bJournal of vascular surgery _cNov 2014 |
||
300 |
_a1218-1226 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAspirin _xtherapeutic use |
650 | 0 | 4 | _aAsymptomatic Diseases |
650 | 0 | 4 | _aBlood Flow Velocity |
650 | 0 | 4 |
_aCardiovascular Agents _xtherapeutic use |
650 | 0 | 4 |
_aCarotid Stenosis _xcomplications |
650 | 0 | 4 | _aChi-Square Distribution |
650 | 0 | 4 | _aComorbidity |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFibrinolytic Agents _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xtherapeutic use |
650 | 0 | 4 |
_aIschemic Attack, Transient _xetiology |
650 | 0 | 4 | _aKaplan-Meier Estimate |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMultivariate Analysis |
650 | 0 | 4 | _aPredictive Value of Tests |
650 | 0 | 4 | _aProportional Hazards Models |
650 | 0 | 4 | _aRegistries |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 |
_aStroke _xetiology |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aUltrasonography, Doppler, Duplex |
700 | 1 | _aMichalczyk, Michael J | |
700 | 1 | _aOpalacz, Arissa | |
700 | 1 | _aPatel, Virendra I | |
700 | 1 | _aLaMuraglia, Glenn M | |
700 | 1 | _aCambria, Richard P | |
773 | 0 |
_tJournal of vascular surgery _gvol. 60 _gno. 5 _gp. 1218-1226 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jvs.2014.05.047 _zAvailable from publisher's website |
999 |
_c24023687 _d24023687 |